Organization: Health Canada
Year: 2024
Month: January
Request Number: A-2023-000847
Request Summary: Adverse Drug Reactions (ADRs) for Tavneos. Report numbers: E2B_06476280, E2B_06503137. ADR for Rexulti: E2B_06469898. ADR for Rexulti. Report number: E2B_06469898. ADR for Rexulti and Aripiprazole. Report number: E2B_06501539. ADRs for Ablify Maintena. Report numbers: 001048638, 001048913, 001050459, 001050957, 001051278. ADR for Aripiprazole. Report number: E2B_06507796.
Disposition: Disclosed in part
Number of pages: 121